Yonsei University

InstitutionResearch output, impact & collaborations

Yonsei University is a research organisation in Seoul, KR. OpenAlex records 181,416 works and 13,619,837 citations for it. 44,037 researchers list it as their most recent affiliation.

181,416

Works

13,619,837

Citations

44,037

Researchers

65.8

Avg h-index

IDs:ROR OpenAlex

How has Yonsei University's publication output changed over time?

ScholarIQpublication output · 2004–2023

Output grew0% over the shown period — from 1 works in 2004 to 1 in 2023.

2004200520092014201620172019202020212023

Who are the most-cited researchers behind Yonsei University?

ScholarIQtop researchers by citations

Beom Kyung Kim · Liver Disease Diagnosis and Treatment

515 works10,003 citations

Heung Dong Kim · Epilepsy research and treatment

376 works9,835 citations

Jong Ho Moon · Gallbladder and Bile Duct Disorders

538 works8,841 citations

Ara Ko · Epilepsy research and treatment

86 works6,006 citations

Byungjin Hwang · CRISPR and Genetic Engineering

39 works2,629 citations

What are the most-cited papers on Yonsei University?

ScholarIQmost cited works

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L. Baehner, Michael G. Walker, Drew Watson, Taesung Park, W. Douglas B. Hiller, Edwin R. Fisher, D. Lawrence Wickerham, John Bryant, Norman Wolmark

New England Journal of Medicine. 20046,385 CitationsOPEN ACCESS

Osimertinib in Untreated <i>EGFR</i> -Mutated Advanced Non–Small-Cell Lung Cancer

Jean‐Charles Soria, Yuichiro Ohe, Johan Vansteenkiste, Thanyanan Reungwetwattana, Busyamas Chewaskulyong, Ki Hyeong Lee, Arunee Dechaphunkul, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata, Isamu Okamoto, Caicun Zhou, Byoung Chul Cho, Ying Cheng, Eun Kyung Cho, Pei Jye Voon, David Planchard, Wu‐Chou Su, Jhanelle E. Gray, Siow Ming Lee, Rachel Hodge, Marcelo Marotti, Yuri Rukazenkov, Suresh S. Ramalingam

New England Journal of Medicine. 20175,376 CitationsOPEN ACCESS

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer, Nancy E. Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A. Kaufman, Sandra M. Swain, Thomas M. Pisansky, Louis Fehrenbacher, Leila A. Kutteh, Victor G. Vogel, Daniel W. Visscher, Greg Yothers, Robert B. Jenkins, Ann Brown, Shaker R. Dakhil, Eleftherios P. Mamounas, Wilma L. Lingle, Pamela Klein, James N. Ingle, Norman Wolmark

New England Journal of Medicine. 20055,365 CitationsOPEN ACCESS

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P. Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa, Sandra M. Swain, Tatiana M. Prowell, Sibylle Loibl, D. Lawrence Wickerham, Jan Bogaerts, José Baselga, Charles M. Perou, Gideon M. Blumenthal, Jens‐Uwe Blohmer, Eleftherios P. Mamounas, Jonas Bergh, Semiglazov Vf, Robert Justice, Holger Eidtmann, Soonmyung Paik, Martine Piccart, Rajeshwari Sridhara, Peter A. Fasching, Leen Slaets, Shenghui Tang, Bernd Gerber, Charles E. Geyer, Richard Pazdur, Nina Ditsch, Priya Rastogi, W. Eiermann, Gϋnter von Minckwitz

The Lancet. 20144,765 CitationsOPEN ACCESS

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia, Augusto Villegas, Davey B. Daniel, David Vicente, Shuji Murakami, Rina Hui, Takashi Yokoi, Alberto Chiappori, Ki Hyeong Lee, Maike de Wit, Byoung Chul Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young‐Chul Kim, Christos S. Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle E. Gray, Luis Paz‐Ares, Javier de Castro, Catherine Wadsworth, Giovanni Melillo, Haiyi Jiang, Yifan Huang, Phillip A. Dennis, Mustafa Özgüroğlu

New England Journal of Medicine. 20174,592 CitationsOPEN ACCESS